Kennedy disease in two sisters with biallelic CAG expansions of the androgen receptor gene

Efficacy and safety of leuprorelin acetate for subjects with spinal and bulbar muscular atrophy: pooled analyses of two randomized-controlled trials

(2019) Atsushi Hashizume et al.   JOURNAL OF NEUROLOGY

Molecular Mechanisms and Therapeutics for SBMA/Kennedy’s Disease

(2019) Frederick J. Arnold et al.   Neurotherapeutics

Kennedy’s disease (spinal and bulbar muscular atrophy): a clinically oriented review of a rare disease

(2018) Marianthi Breza et al.   JOURNAL OF NEUROLOGY

Beyond motor neurons: expanding the clinical spectrum in Kennedy’s disease

(2018) Raquel Manzano et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Nonalcoholic fatty liver disease in spinal and bulbar muscular atrophy

(2017) Robert D. Guber et al.   NEUROLOGY

A population-based epidemiologic study of adult neuromuscular disease in the Republic of Ireland

(2016) Stela Lefter et al.   NEUROLOGY

Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis

(2014) Wen-Lung Ma et al.   ENDOCRINE-RELATED CANCER

Neurotoxic effects of androgens in spinal and bulbar muscular atrophy

(2011) Sara Parodi et al.   FRONTIERS IN NEUROENDOCRINOLOGY

Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trial

(2011) Lindsay E Fernández-Rhodes et al.   LANCET NEUROLOGY

Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial

(2010) Masahisa Katsuno et al.   LANCET NEUROLOGY

Clinical features of spinal and bulbar muscular atrophy

(2009) Lindsay E. Rhodes et al.   BRAIN

Spinal and bulbar muscular atrophy: Skeletal muscle pathology in male patients and heterozygous females

(2007) Gianni Sorarù et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES